Document Detail

Understanding the mechanisms of human tubal ectopic pregnancies: new evidence from knockout mouse models.
Jump to Full Text
MedLine Citation:
PMID:  20023297     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ectopic pregnancy, a worldwide health problem, is potentially life-threatening and occurs in approximately 1.5-2% of all pregnancies in the western world; however, the precise mechanisms underlying the initiation and development of tubal ectopic pregnancy are unknown. Tubal abnormalities and dysfunction, such as altered contractility or abnormal ciliary activity, have been speculated to lead to tubal ectopic pregnancy. To elucidate the cellular and molecular mechanisms of the tubal transport process, several knockout (KO) mouse models have been developed. This review summarizes what has been learned from studies of the Fallopian tube in caspase-1, cannabinoid receptor and Dicer1 KO mice. Our understanding of the mechanisms which contribute to tubal ectopic pregnancy in humans may be enhanced through further study of these KO mouse models.
Authors:
Ruijin Shao
Related Documents :
2004527 - Timing of postpartum tubal sterilization using the filshie clips: an analysis of data f...
18602767 - Serious and deadly complications from pregnancy after endometrial ablation: two case re...
10498027 - Laparoscopic microsurgery: current and future status.
2904417 - Treatment of hydrosalpinx using a single incision eversion procedure.
9283277 - Defining and measuring unintended pregnancy: issues and concerns.
22632287 - An outbreak of severe iodine-deficiency goitre in a sheep flock in north-east victoria.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2009-12-19
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  25     ISSN:  1460-2350     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-09     Completed Date:  2010-04-23     Revised Date:  2010-09-28    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  584-7     Citation Subset:  IM    
Affiliation:
Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Caspase 1 / deficiency,  genetics
Disease Models, Animal
Endocannabinoids / physiology
Estradiol / physiology
Fallopian Tubes / physiology*,  physiopathology
Female
Humans
Mice
Mice, Knockout
Pregnancy
Pregnancy, Ectopic / etiology*
Receptor, Cannabinoid, CB1 / deficiency,  genetics
Ribonuclease III / deficiency,  genetics
Chemical
Reg. No./Substance:
0/Endocannabinoids; 0/Receptor, Cannabinoid, CB1; 50-28-2/Estradiol; EC 3.1.26.3/Ribonuclease III; EC 3.4.22.36/Caspase 1
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Hum Reprod
Journal ID (publisher-id): humrep
Journal ID (hwp): humrep
ISSN: 0268-1161
ISSN: 1460-2350
Publisher: Oxford University Press
Article Information
Download PDF
? The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
creative-commons:
Received Day: 30 Month: 7 Year: 2009
Revision Received Day: 6 Month: 11 Year: 2009
Accepted Day: 19 Month: 11 Year: 2009
Print publication date: Month: 3 Year: 2010
Electronic publication date: Day: 19 Month: 12 Year: 2009
pmc-release publication date: Day: 19 Month: 12 Year: 2009
Volume: 25 Issue: 3
First Page: 584 Last Page: 587
ID: 2817566
PubMed Id: 20023297
DOI: 10.1093/humrep/dep438
Publisher Id: dep438

Understanding the mechanisms of human tubal ectopic pregnancies: new evidence from knockout mouse models
Ruijin Shao1
Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
1Correspondence address. Tel: +46-31-7863408; Fax +46-31-7863512; E-mail: ruijin.shao@fysiologi.gu.se; URL: http://www.neurophys.gu.se/sektioner/fysiologi/endo/staff/ruijin_shao/

Introduction

The aetiologies of many female reproductive tract diseases are unknown. Approximately 21 of 1000 reported pregnancies and 1 of 1000 women between 15 and 44 years old are diagnosed with ectopic pregnancy annually in the USA (Van Den Eeden et al., 2005). However, throughout the western world ectopic pregnancy is estimated to occur in approximately 1.5?2% of all pregnancies (Barnhart, 2009). More than 95% of all ectopic pregnancies are located in the Fallopian tube (Corpa, 2006). Women with tubal ectopic pregnancy (tEP) not only have an increased rate of infertility, but also have an increased risk for tEP in future pregnancies (Farquhar, 2005). Fallopian tube transport of the gamete and early embryo into the uterus is crucial for the establishment of pregnancy in mammals (Jansen, 1984). Abnormalities in the structure and function of the Fallopian tube can interfere with the gamete/early embryo transport process and lead to tEP (Farquhar, 2005); however, the molecular mechanisms underlying this interference are not well characterized. Although several related risk factors have been proposed, such as pelvic infections, past or ever smoker and endometriosis (Farquhar, 2005; Corpa, 2006), the lack of appropriate animal models to study tubal transport limits our understanding of the development of human tEP at the cellular and molecular levels. This paper provides an overview of current progress in our understanding of the molecular mechanisms responsible for tubal dysfunction gained from studies of genetically modified mice along side clinical studies, and a perspective on the importance of integrating the phenotype analysis as a tool for identifying and understanding the biological pathways in tubal dysfunction.


Rodent models to study Fallopian tube function

The mammalian Fallopian tube is a dynamic, steroid-responsive tissue (Jansen, 1984). The hormone 17?-estradiol (E2) is implicated in the regulation of cell proliferation, differentiation and apoptosis in the Fallopian tube (Monroe et al., 2002). The key to the biological effects of E2 is the activation of intracellular estrogen receptors (ER), which are ligand-inducible transcription factors that regulate the expression of many genes that control physiological processes (Dougherty and Sanders, 2005). Withdrawal of E2 has been shown to induce cell death and increase levels of caspase-1 mRNA in the hen Fallopian tube (Monroe et al., 2002). Our preliminary results, obtained by western blot and immunofluorescence assay, indicate that caspase-1 is expressed in human and mouse Fallopian tubes (unpublished data). Since human and rodent Fallopian tube cells express both ER? and ER? (Shao et al., 2007a, b; Horne et al., 2009), it would be predicted that the transcriptional regulation of caspase-1 is ER-dependent in the Fallopian tube in vivo; however, the primary function of caspase-1 is to activate inflammatory cytokines rather than promote cell death in the Fallopian tube. When compared with wild-type mice, female mice with a targeted deletion of caspase-1 (Cheng et al., 2008) were less susceptible to tubal inflammatory pathologies, such as the inflammatory infiltration and hydrosalpinx formation by Chlamydia trachomatis infection, one of the common risk factors for the induction of tEP in humans (Farquhar, 2005; Barnhart, 2009). More recently, caspase-1 inhibitor (Z-YVAD-fmk, Biovision, Mountain View, CA, USA) has been shown to suppress the growth and development of C. trachomatis in infected cervical epithelial cells in vitro (Abdul-Sater et al., 2009). Such an observation implies that the activation of caspase-1 may result in the epithelial cells undergoing an inflammatory process during chlamydial infection in vivo. Therefore, further investigations to determine how the activation of endogenous caspase-1 affects the severity of the pathological tubal phenotype are warranted. We have previously shown that the tubal transport of oocyte?cumulus complex in superovulated immature mice is significantly enhanced or blocked in the presence of E2 or the ER antagonist ICI 182780, respectively, demonstrating effects on ER-mediated tubal transport (Shao et al., 2009a). In agreement with the known role of estrogen in regulating pro- or anti-inflammatory dynamics depending on the tissue/cell type involved, we hypothesize that abrogated E2/ER signalling and caspase-1-mediated inflammation in the Fallopian tube possibly contribute to infection-induced tEP. We can also expect that the use of caspase-1 knockout (KO) mice treated with E2 and/or an inducer of inflammation will help us to elucidate novel genes and pathways that play a functional role in the process of tubal transport.

Endocannabinoids, a group of endogenous neuromodulatory lipids, are known to activate two G protein-coupled cannabinoid receptors CB1 and CB2 (Taylor et al., 2007), which are widely and differentially expressed in many tissues and organs. It has been shown that only CB1 is expressed in the Fallopian tube, and the levels of tubal CB1 in the follicular phase are lower than those in the luteal phase in humans (Horne et al., 2008). Progesterone action, via binding to the progesterone receptor, is involved in cellular function in the Fallopian tube (Shao et al., 2006; W?nggren et al., 2008). Although the steroid hormone regulation of tubal CB1 expression has not yet been reported, elevated progesterone levels in the luteal phase have been proposed as a regulator of Fallopian tube CB1 expression (Horne et al., 2008). The biological importance of CB1 in the tubal transport process is illustrated by the presence of retained embryos in mice that lack either CB1 or CB1/2, or mice that have been treated with synthetic CB1 antagonist (Wang et al., 2004). In contrast to CB1 and CB1/2 KO mice, tubal transport is not affected in CB2 KO mice (Wang et al., 2008): this difference in phenotype may reflect a differential distribution of CB receptors in the mouse Fallopian tube. Moreover, clinical validation of the close association between CB1 expression and human tEP comes from the fact that a decrease in CB1 mRNA expression in the Fallopian tube is observed in women with tEP (Horne et al., 2008). Previously, Paria et al. (1996) reported that the Fallopian tubes of pregnant mice are capable of synthesizing anandamide, a metabolic ligand for CB receptors. While smoking is one of the risk factors for the development of tEP (Farquhar, 2005), pre-clinical studies have shown that nicotine exposure results in changes in endocannabinoid content in the brain (Le Foll et al., 2008). Moreover, it has been speculated that an imbalance in endocannabinoid levels in the circulation and reproductive tissues in humans may be associated with an increased incidence of ectopic pregnancy (Taylor et al., 2007). These observations, although limited, provide compelling evidence that disturbances of endocannabinoid/CB1 signalling during tubal transport could result in the development of tEP in humans. The success of future experiments to identify the significant loci of CB1 that predispose individuals to the common form of human tEP will depend on the biological complexity of this disorder (Horne et al., 2008). Interestingly, induction of inflammation has been shown to inhibit CB1-mediated uterine contraction in rats (Dmitrieva and Berkley, 2002). Therefore, it is tempting to hypothesize that the inhibition of tubal CB1 signalling by the in vivo action of cannabinoids may also contribute to inflammation-induced tubal cell injury, and thus, influence tubal transport.

Dicer (encoded by Dicer1), a ribonuclease III enzyme required for micro-RNA processing, has been demonstrated to play an essential role in embryo implantation in mice and in the human endometrium under pathophysiological conditions, such as endometriosis (Hong et al., 2008). While the complete loss of Dicer1 in mice results in early embryonic lethality (Bernstein et al., 2003), a considerable number of studies in female mice carrying a floxed allele of Dicer1 under the control of antim?llerian hormone receptor 2 promoter-driven Cre recombinase has revealed that these mice exhibit tubal hypotrophy with the formation of prominent tubal cysts, leading to the disruption of tubal transport (Hong et al., 2008; Nagaraja et al., 2008; Gonzalez and Behringer, 2009), which is likely a result of abnormalities in the function of the uterotubal junction (Gonzalez and Behringer, 2009). Moreover, disorganization of epithelial cells and smooth muscle cells (Gonzalez and Behringer, 2009) was found to correlate with alterations in the expression of tubal epithelial and smooth muscle cell markers after the removal of Dicer (Nagaraja et al., 2008); however, impaired ciliogenesis and ciliated function were not observed in tissue-specific Dicer1 KO mouse Fallopian tubes (Gonzalez and Behringer, 2009). To date, there are no published reports regarding the expression and regulation of tubal Dicer1 in humans during tubal transport and in tEP. A more conclusive understanding of the precise mechanisms of how aberrant Dicer1 protein leads to human tEP will require further study; however, the results discussed herein support the notion that the Dicer-mediated integrity of normal tubal structure and function is necessary for tubal transport. Although there is no difference in circulating E2 levels between Dicer1 KO and wild-type mice (Hong et al., 2008; Gonzalez and Behringer, 2009), it has recently been reported that E2 is able to rapidly up-regulate Dicer1 gene expression through ER? activation in luminal-type A/ER?-positive breast cancer cells in vitro (Bhat-Nakshatri et al., 2009). The differences between the KO study in vivo and the ER agonist results in vitro may be accounted for by the differences in acute versus chronic effects of E2 in tissues/cells. Thus, in the Fallopian tube, it cannot be completely ruled out that time-dependent E2 action regulates the micro-RNA pathway by affecting Dicer expression.


Summary and perspective

There is a gap in our knowledge about the precise reasons for and the mechanisms underlying the implantation of an embryo in the Fallopian tube (Farquhar, 2005). Fallopian tube function is regulated by complex physiological and molecular processes, and therefore, the development of genetically modified animal models provides a powerful means to specifically investigate the impact of particular molecules and their discreet pathways in tubal function, as well as pathologies arising from the dysregulaion of these molecules. The deletion of CB1 or Dicer1 in mice results in the retention of an oocyte/embryo within the Fallopian tube and may provide clues for tubal abnormality-induced tEP in humans. It is important to note that while mice are genetically similar to humans and both share features of tubal cell physiology, tEP is present in humans but is absent or rare in rodents (Corpa, 2006). It is possible that the molecular mechanisms involved in tubal transport may be different in mice and humans, thus, not all of the information gained from mouse models may be applicable to human disease. The mammalian Fallopian tube is composed of heterogeneous cell types: ciliated and secretory epithelial cells as well as smooth muscle cells, all of which appear to be specialized to perform different functions (Shao et al., 2007a, b). Although the intricate manner by which numerous factors regulate the process of tubal transport is clear, available studies indicate that ciliary beating and smooth muscle activity are the major factors responsible for propelling the gametes and embryo through the Fallopian tube (Jansen, 1984). Mechanisms regulating ciliary beating and smooth muscle activity are complex, and they can be either coordinately or independently responsible for different stages of tubal transport. In tubal cells, altered gene expression must presumably underlie the process of tubal transport. Therefore, extensive studies of temporal changes in the gene expression and in cell-specific signalling pathways in the Fallopian tube will be essential in order to understand the contribution of each of these factors to tubal function. Genetically modified mouse models could help us to elucidate the underlying molecular mechanisms that are responsible for ciliary beating and muscular activity in the Fallopian tube in vivo under physiological conditions and in diseased states. A first step would be to develop an in vitro tubal cell/organ culture system in which gene programmes/pathways could be manipulated and possibly scrutinized by microarray procedures. The net results of these future studies combined with information from KO mouse models will add further important insight into the biology of tubal transport processes. Moreover, the key issue becomes one of whether CB1 or Dicer1 levels are regulated during tubal transport under physiological conditions, thus, the contribution of CB1 and Dicer1 to the process of tubal transport in wild-type mice in vivo needs to be evaluated. Finally, experiments designed to rescue CB1 or Dicer1 KO mice from the disruption of tubal transport observed in these models are needed to test the role of potential therapeutic targets. The coordination of oocyte/embryo?tubal epithelial cell interaction plays a role in this process (Jansen, 1984), and abnormalities in this interaction may also alter the timely homing of the oocyte/embryo in the Fallopian tube (Shao et al., 2009b); hence, a combination of different strategies and clinical studies (Barnhart, 2009) is necessary to dissect the mechanisms underlying tEP, still a poorly understood tubal disorder.


Funding

The Swedish Medical Research Council (grant 5859), the Sahlgrenska Academy Research Council and G?teborgs L?kares?llskap.


Acknowledgements

The author would like to thank Profs H?kan Billig, Mats Br?nnstr?m and Dr Emil Egecioglu for their useful comments and discussions.


References
Abdul-Sater AA,Koo E,Hacker G,Ojcius DM. Inflammasome-dependent caspase-1 activation in cervical epithelial cells stimulates growth of the intracellular pathogen Chlamydia trachomatisJ Biol ChemYear: 2009284267892679619648107
Barnhart KT. Clinical practice. Ectopic pregnancyN Engl J MedYear: 200936137938719625718
Bernstein E,Kim SY,Carmell MA,Murchison EP,Alcorn H,Li MZ,Mills AA,Elledge SJ,Anderson KV,Hannon GJ. Dicer is essential for mouse developmentNat GenetYear: 20033521521714528307
Bhat-Nakshatri P,Wang G,Collins NR,Thomson MJ,Geistlinger TR,Carroll JS,Brown M,Hammond S,Srour EF,Liu Y,et al. Estradiol-regulated microRNAs control estradiol response in breast cancer cellsNucleic Acids ResYear: 2009374850486119528081
Cheng W,Shivshankar P,Li Z,Chen L,Yeh IT,Zhong G. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infectionInfect ImmunYear: 20087651552218025098
Corpa JM. Ectopic pregnancy in animals and humansReproductionYear: 200613163164016595714
Dmitrieva N,Berkley KJ. Contrasting effects of WIN 55212?2 on motility of the rat bladder and uterusJ NeurosciYear: 2002227147715312177210
Dougherty DC,Sanders MM. Estrogen action: revitalization of the chick oviduct modelTrends Endocrinol MetabYear: 20051641441916202618
Farquhar CM. Ectopic pregnancyLancetYear: 200536658359116099295
Gonzalez G,Behringer RR. Dicer is required for female reproductive tract development and fertility in the mouseMol Reprod DevYear: 20097667868819197916
Hong X,Luense LJ,McGinnis LK,Nothnick WB,Christenson LK. Dicer1 is essential for female fertility and normal development of the female reproductive systemEndocrinologyYear: 20081496207621218703631
Horne AW,Phillips JA 3rd,Kane N,Lourenco PC,McDonald SE,Williams AR,Simon C,Dey SK,Critchley HO. CB1 expression is attenuated in fallopian tube and decidua of women with ectopic pregnancyPLoS OneYear: 20083e396919093002
Horne AW,King AE,Shaw E,McDonald SE,Williams AR,Saunders PT,Critchley HO. Attenuated sex steroid receptor expression in fallopian tube of women with ectopic pregnancyJ Clin Endocrinol MetabYear: 2009945146515419864448
Jansen RP. Endocrine response in the fallopian tubeEndocr RevYear: 198455255516094174
Le Foll B,Forget B,Aubin HJ,Goldberg SR. Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studiesAddict BiolYear: 20081323925218482433
Monroe DG,Berger RR,Sanders MM. Tissue-protective effects of estrogen involve regulation of caspase gene expressionMol EndocrinolYear: 2002161322133112040018
Nagaraja AK,Andreu-Vieyra C,Franco HL,Ma L,Chen R,Han DY,Zhu H,Agno JE,Gunaratne PH,DeMayo FJ,et al. Deletion of Dicer in somatic cells of the female reproductive tract causes sterilityMol EndocrinolYear: 2008222336235218687735
Paria BC,Deutsch DD,Dey SK. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation periodMol Reprod DevYear: 1996451831928914076
Shao R,Weijdegard B,Ljungstrom K,Friberg A,Zhu C,Wang X,Zhu Y,Fernandez-Rodriguez J,Egecioglu E,Rung E,et al. Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular functionAm J Physiol Endocrinol MetabYear: 2006291E59E7216449295
Shao R,Egecioglu E,Weijdegard B,Kopchick JJ,Fernandez-Rodriguez J,Andersson N,Billig H. Dynamic regulation of estrogen receptor-alpha isoform expression in the mouse fallopian tube: mechanistic insight into estrogen-dependent production and secretion of insulin-like growth factorsAm J Physiol Endocrinol MetabYear: 2007a293E1430E144217848632
Shao R,Weijdegard B,Fernandez-Rodriguez J,Egecioglu E,Zhu C,Andersson N,Thurin-Kjellberg A,Bergh C,Billig H. Ciliated epithelial-specific and regional-specific expression and regulation of the estrogen receptor-beta2 in the fallopian tubes of immature rats: a possible mechanism for estrogen-mediated transport process in vivoAm J Physiol Endocrinol MetabYear: 2007b293E147E15817374697
Shao R,Nutu M,Karlsson-Lindahl L,Benrick A,Weijdegard B,Lager S,Egecioglu E,Fernandez-Rodriguez J,Gemzell-Danielsson K,Ohlsson C,et al. Downregulation of cilia-localized Il-6R{alpha} by 17{beta}-estradiol in mouse and human fallopian tubesAm J Physiol Cell PhysiolYear: 2009a297C140C15119420002
Shao R,Nutu M,Weijdegard B,Egecioglu E,Fernandez-Rodriguez J,Karlsson-Lindahl L,Gemzell-Danielsson K,Bergh C,Billig H. Clomiphene citrate causes aberrant tubal apoptosis and estrogen receptor activation in rat fallopian tube: implications for tubal ectopic pregnancyBiol ReprodYear: 2009b801262127119211805
Taylor AH,Ang C,Bell SC,Konje JC. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancyHum Reprod UpdateYear: 20071350151317584820
Van Den Eeden SK,Shan J,Bruce C,Glasser M. Ectopic pregnancy rate and treatment utilization in a large managed care organizationObstet GynecolYear: 20051051052105715863544
Wang H,Guo Y,Wang D,Kingsley PJ,Marnett LJ,Das SK,DuBois RN,Dey SK. Aberrant cannabinoid signaling impairs oviductal transport of embryosNat MedYear: 2004101074108015378054
Wang H,Xie H,Dey SK. Loss of cannabinoid receptor CB1 induces preterm birthPLoS OneYear: 20083e332018833324
W?nggren K,Stavreus-Evers A,Olsson C,Andersson E,Gemzell-Danielsson K. Regulation of muscular contraction in the human Fallopian tube through prostaglandings and progesteronesHum ReprodYear: 2008232359235818621753

Article Categories:
  • Mini-Review: Developments in Reproductive Biology and Medicine

Keywords: tubal ectopic pregnancy, animal models, knockout mice, Fallopian tube, endocannabinoids.

Previous Document:  The experience of spontaneous pregnancy loss for infertile women who have conceived through assisted...
Next Document:  Establishment of a protein frequency library and its application in the reliable identification of s...